Amalgamated Financial (AMAL) Executive Receives 13,846 Restricted Stock Units
Rhea-AI Filing Summary
Sam D. Brown, Senior Executive Vice President and Chief Banking Officer of Amalgamated Financial Corp. (AMAL), was awarded 13,846 restricted stock units on 09/01/2025. The award was granted at no cash cost (price $0) and increases the reporting person’s total beneficial ownership to 55,626.67 shares. The restricted stock units vest in three equal annual installments beginning on the first anniversary of the grant date, with each unit representing a contingent right to receive one share of AMAL common stock.
Positive
- Retention and alignment: 13,846 restricted stock units vesting over three years align the Chief Banking Officer’s incentives with shareholder value.
- Clear disclosure: Form 4 specifies grant date, unit count, zero cash price, vesting schedule, and resulting beneficial ownership, meeting reporting requirements.
Negative
- None.
Insights
TL;DR: A routine executive RSU grant that aligns compensation with shareholder outcomes; likely neutral for near-term valuation.
The grant of 13,846 restricted stock units to the Chief Banking Officer is a standard equity-based retention and incentive mechanism. The units vest over three years starting one year after grant, which ties a portion of the executive’s compensation to future share performance and promotes retention. The reported post-grant beneficial ownership of 55,626.67 shares provides context on the executive’s stake but does not quantify percentage ownership or dilution relative to outstanding shares, so material market impact appears limited based solely on this filing.
TL;DR: Compensation appears structured for retention and alignment; disclosure is clear and typical for Form 4 reporting.
The filing discloses customary terms: grant date, number of restricted stock units, zero cash price, vesting schedule over three annual installments, and the conversion ratio of one unit to one share. This level of detail satisfies Section 16 reporting expectations. The filing does not indicate acceleration conditions, performance vesting, or any derivative instruments tied to the award, limiting further governance implications from the disclosed information.